Trial Profile
Management of Hepatitis C Virus (HCV) Infection in Pregnant Women With Opioid Use Disorder (OUD): the Potential of an Integrated Medical Home Model: Phase IV Trial of Sofosbuvir/Velpatasvir (SOF/VEL) in Postpartum Women With Chronic HCV
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 May 2023
Price :
$35
*
At a glance
- Drugs Sofosbuvir/velpatasvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 19 Aug 2022 Status changed from recruiting to completed.
- 06 Oct 2021 Planned End Date changed from 30 Aug 2021 to 30 Aug 2023.
- 16 Aug 2021 Planned End Date changed from 1 Jul 2021 to 30 Aug 2021.